A new framework for acupoint specificity: Advancing acupuncture studies using the double-dissociation model
Chae et al. · Integrative Medicine Research · 2026
Evidence Level
STRONGOBJECTIVE
Propose a new methodological double-dissociation model to test the functional specificity of acupuncture points
WHO
Researchers and practitioners interested in the scientific validation of acupoint specificity
DURATION
Enduring framework for future studies
POINTS
PC-6 (cardiovascular) and ST-36 (gastric function) as the application model
🔬 Study Design
Proposed Model
n=0
Theoretical framework for future studies with PC-6 and ST-36
📊 Results in numbers
Limitation of current studies
Improvement in causal inference
Functional specificity
Applicability
Percentage highlights
📊 Outcome Comparison
Methodological rigor
Causal inference
This study proposes a new way to research whether different acupuncture points truly have specific functions. Instead of testing only one point at a time, the researchers suggest comparing two different points (PC-6 for the heart and ST-36 for the stomach) simultaneously, measuring both functions. This would help scientifically prove that each point has its specific function, strengthening the scientific basis of acupuncture.
Article summary
Plain-language narrative summary
This groundbreaking article proposes a new methodological paradigm for acupuncture research, addressing a fundamental and controversial issue in the field: the functional specificity of acupoints. The authors, led by specialists from renowned South Korean and Taiwanese institutions, present the double-dissociation model, adapted from cognitive neurosciences, as a rigorous tool for scientifically testing whether different acupuncture points truly possess specific physiological functions.
The central problem identified by the researchers lies in the methodological limitations of current studies, which predominantly use single-dissociation designs. These studies typically compare an acupoint with a control or sham point, measuring only a single primary outcome. Although they can demonstrate efficacy, these designs are insufficient to establish true functional specificity, as they cannot distinguish between point-specific effects and generalized physiological responses.
The proposed double-dissociation framework represents a significant methodological advance. The model simultaneously tests two theoretically distinct acupoints (PC-6 and ST-36) against two separable physiological domains (cardiovascular and gastric function). The point PC-6, traditionally associated with cardiovascular regulation, would be tested for its ability to preferentially modulate blood pressure over gastric function. Simultaneously, ST-36, known for its gastrointestinal effects, would be assessed for its preferential influence on gastric motility relative to cardiovascular parameters.
The strength of this approach lies in the demonstration of cross-selectivity: if PC-6 produces greater changes in cardiovascular parameters than in gastric parameters, while ST-36 exerts greater influence on gastric function than on cardiovascular parameters, this would constitute robust evidence of functional specificity. This pattern of crossover interaction cannot be easily explained by generalized factors such as nonspecific somatosensory stimulation or placebo effects.
The proposed methodology would include simultaneous measurements of beat-to-beat blood pressure, heart rate variability, electrogastrography, and quantitative indices of gastric motility. The statistical analysis would focus on the acupoint × outcome domain interaction term, using mixed-effects models to partition the variance attributable to shared autonomic fluctuations.
The authors acknowledge important limitations of the model. The selection of acupoints and outcome measures must ensure true functional separability. The example presented of a previous study that failed to demonstrate double dissociation between acupoints for pain and depression illustrates the importance of choosing systems with at least partially independent regulatory circuits.
The clinical implications are substantial. Scientific validation of acupoint specificity would strengthen the theoretical basis of acupuncture and facilitate its integration into modern biomedical care. The framework can be generalized to other clinically important acupoints and point combinations, opening new avenues of research.
This work represents a proof-of-concept contribution intended to stimulate future empirical studies that formally test the specific effects of acupoints using double-dissociation designs. Aligning acupuncture research with contemporary neuroscientific standards for demonstrating functional specialization marks a significant step in the scientific maturation of the field.
Strengths
- 1Rigorous methodological framework adapted from cognitive neurosciences
- 2Innovative approach to resolve a long-standing controversy regarding specificity
- 3Universal applicability to other acupoints and combinations
- 4Robust control for confounders and nonspecific effects
- 5Alignment with contemporary scientific standards
Limitations
- 1Absence of empirical data — proposal only
- 2Need for careful selection of acupoints and outcomes
- 3Possible overlap between cardiovascular and gastric systems
- 4Methodological complexity may limit implementation
- 5Requires validation through future studies
Expert Commentary
Dr. Marcus Yu Bin Pai
MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture
▸ Clinical Relevance
The question of acupoint specificity is no longer merely philosophical — it has direct impact on how we justify and prescribe acupuncture in pain and rehabilitation services. The double-dissociation model proposed by Chae et al. offers the clinician a solid methodological argument to defend, before scientific committees and skeptical peers, that point location matters physiologically. In daily practice, when we select PC-6 for autonomic modulation in patients with chronic pain associated with cardiovascular dysfunction, or ST-36 in patients with gastrointestinal comorbidity and central pain syndrome, we are making choices based on premises that the literature has not yet been able to test rigorously. This framework provides the scaffolding for future studies to confirm or refute those choices with the same methodological robustness we require of pharmacological trials.
▸ Notable Findings
The most intriguing aspect of the work is the transposition of the double-dissociation model from cognitive neurosciences to acupuncture research — an intellectually elegant move that resolves the structural problem of single-dissociation designs. By requiring PC-6 to demonstrate cardiovascular superiority over ST-36 and, simultaneously, that ST-36 demonstrate gastric superiority over PC-6, the model creates a crossover interaction pattern that cannot be attributed to nonspecific somatosensory stimulation or placebo effect. The proposal to measure, in parallel, heart rate variability and electrogastrography as separable outcomes is particularly surgical: these are autonomic biomarkers with regulatory pathways sufficiently independent to make the experiment interpretable. The estimate that 90% of current studies operate with designs insufficient to establish true specificity forcefully quantifies the gap the framework seeks to fill.
▸ From My Experience
In my practice at the musculoskeletal pain clinic, acupoint selection has never been random — we combine local points with distal points precisely because of the specificity premise this article now seeks to validate empirically. I have observed that patients with autonomic dysfunction associated with chronic pain respond qualitatively differently when we include PC-6 in the protocol, compared with protocols that omit that point. Similarly, patients with central sensitization syndrome and digestive comorbidity often report gastrointestinal improvement when ST-36 is part of the protocol. These clinical impressions accumulated over years are exactly what lacks the experimental support that Chae et al. propose to generate. The patient profile that would benefit most from studies derived from this framework is one with objectively measurable autonomic comorbidities, since these patients allow us to distinguish specific effect from global response. I typically begin to see clinical response between the third and fifth session in autonomic protocols, with maintenance in cycles of eight to ten sessions — and it would be valuable to have specificity data to optimize that prescription.
Full original article
Read the full scientific study
Integrative Medicine Research · 2026
DOI: 10.1016/j.imr.2026.101316
Access original articleScientific Review

Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories